Journal article icon

Journal article

Natural variation in Fc glycosylation of HIV-specific antibodies impacts antiviral activity

Abstract:
While the induction of a neutralizing antibody response against HIV remains a daunting goal, data from both natural infection and vaccine-induced immune responses suggest that it may be possible to induce antibodies with enhanced Fc effector activity and improved antiviral control via vaccination. However, the specific features of naturally induced HIV-specific antibodies that allow for the potent recruitment of antiviral activity and the means by which these functions are regulated are poorly defined. Because antibody effector functions are critically dependent on antibody Fc domain glycosylation, we aimed to define the natural glycoforms associated with robust Fc-mediated antiviral activity. We demonstrate that spontaneous control of HIV and improved antiviral activity are associated with a dramatic shift in the global antibody-glycosylation profile toward agalactosylated glycoforms. HIV-specific antibodies exhibited an even greater frequency of agalactosylated, afucosylated, and asialylated glycans. These glycoforms were associated with enhanced Fc-mediated reduction of viral replication and enhanced Fc receptor binding and were consistent with transcriptional profiling of glycosyltransferases in peripheral B cells. These data suggest that B cell programs tune antibody glycosylation actively in an antigen-specific manner, potentially contributing to antiviral control during HIV infection.
Publication status:
Published
Peer review status:
Peer reviewed

Actions

Access Document

Files:
Publisher copy:
10.1172/jci65708

Authors

More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Biochemistry
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Biochemistry
Role:
Author
More by this author
Institution:
University of Oxford
Division:
MSD
Department:
Biochemistry
Role:
Author


More from this funder
Funding agency for:
Nigrovic, P
Grant:
R21-99435
More from this funder
Funding agency for:
Choi, I
Grant:
IIS-0905206
More from this funder
Funding agency for:
Ercan, A
Grant:
K12 HD51959
R01 AI080289
More from this funder
Funding agency for:
Ercan, A
Grant:
K12 HD51959


Publisher:
American Society for Clinical Investigation
Journal:
Journal of clinical investigation More from this journal
Volume:
123
Issue:
5
Pages:
2183-2192
Publication date:
2013-05-01
Acceptance date:
2013-02-07
DOI:
EISSN:
1558-8238
ISSN:
0021-9738


Language:
English
Keywords:
Pubs id:
pubs:405990
UUID:
uuid:128268b8-29d6-48e1-96ae-63677b859747
Local pid:
pubs:405990
Source identifiers:
405990
Deposit date:
2016-02-17
ARK identifier:

Terms of use


Views and Downloads






If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP